Age-stratified clustering of multiple long-term conditions

Anirban Chakraborty; Bruce Guthrie; Sohan Seth

Home/Archive/arXiv

arXiv · 2505.10952

Age-stratified clustering of multiple long-term conditions

Anirban Chakraborty·Bruce Guthrie·Sohan Seth

View original source ↗Read source document ↗Export metadata ↓

Abstract

Background: Most people with any long-term condition have multiple long-term conditions, but our understanding of how conditions cluster is limited. Many clustering studies identify clusters in the whole population, but the clusters that occur in people of different ages may be distinct. The aim of this paper was to explore similarities and differences in clusters found in different age-groups. Method: We present a method for finding similar clusters in multiple age-groups, referred to as cluster sets, using Latent Class Analysis (LCA) and Chebyshev distance metric. We analyse a primary care electronic health record (EHR) dataset recording the presence of 40 long-term conditions (LTCs) in 570,355 people aged 40-99 years with at least one of these conditions, analysing in five-year age-groups. Findings: We find that the 600 clusters found separately in 12 age-strata can be summarised by 342 cluster sets with 263 cluster sets only being found in a single age-group (singleton cluster sets), and 79 cluster sets being present in multiple age-groups. We observe that 31 conditions of the 40 conditions studied appear in cluster sets with the respective condition being the only condition present with a very high prevalence of more than 0.9 whereas the remaining cluster sets typically contain two to four conditions present with a high prevalence of more than 0.7. Interpretation: Multimorbidity profiles in different age-groups are often distinct (singleton cluster sets observed only in that age-group), but similar clusters with small variations in their composition are also found in multiple age-groups. This demonstrates the age dependency of MLTC clusters and presents a case for age-stratified clustering.

Explore related subjects

stat.AP

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Anirban Chakraborty, Bruce Guthrie, Sohan Seth. 2025-05-16. Age-stratified clustering of multiple long-term conditions. https://arxiv.org/abs/2505.10952

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related papers

arXiv2026

Geospatial Foundation Models Capture Health-Relevant Dimensions of Place Beyond Conventional Social Risk Indices

Area-based social risk indices summarize residents' socioeconomic conditions but incompletely capture physical features of place that may affect health. We evaluated whether numerical representations of physical place produced by four geospatial foundation model families from 2022 satellite data explained residual variance in tract-level associations between the Area Deprivation Index, Social Deprivation Index, and Social Vulnerability Index with health outcomes. We used LightGBM to predict variables from the American Community Survey and 40 chronic disease and health-behavior outcomes from CDC PLACES across 82,646 census tracts in the contiguous United States, evaluating performance across 10 held-out states. Among survey variables, models were moderately predictive of some variables including housing type (R-squared up to 0.54) but weak for disability, unemployment, and income disparity. For health outcomes, models explained up to 54% of variance left unexplained by social risk indices, with the largest gains for annual checkups, arthritis, and high blood pressure. Mean total variance explained by geospatial foundation models across the 40 health-related outcomes increased from 0.31 in the smallest tract-size decile to 0.39 in the largest. Geospatial foundation models capture health-relevant features of place not represented by conventional social risk indices and may usefully augment them in epidemiological analyses.

stat.AP↗

arXiv2026

Transporting summary measures of relative effects from randomised trials to the treated patient population: an application to breast cancer endocrine therapy

Randomised trials often report relative treatment effects, such as risk ratios and hazard ratios, for trial populations. Clinical decision-making, however, often benefits from estimates of absolute treatment effects in the population eligible for treatment. Trial participants may not represent this target population well, and restrictions on access to individual participant trial data can further complicate absolute effect estimation. Routine care data are often representative of the target population but may be subject to uncontrolled confounding. We consider estimation of the average treatment effect on the treated (ATT), an absolute measure, by combining a representative sample of treated routine care patients with summary measures (i.e., estimated risk or hazard ratios) from either a randomised trial or a meta-analysis of trials. Under marginal or conditional transportability assumptions, the ATT is shown to be identifiable. The implications of collapsibility of the effect measure on transportability are discussed, and plug-in estimators of the ATT are presented. Simulation studies are used to assess finite sample performance of the estimators in a range of settings. The proposed methods are applied to estimate the ATT of endocrine therapy on 15-year breast cancer mortality using results from a meta-analysis of randomised trials and England's National Disease Registration Service.

stat.AP↗

arXiv2026

Overcoming Model Misspecification in Bayesian Inference of Molecular Signalling Networks

Bayesian inference of molecular signalling networks usually relies on tractability of the marginal likelihood, enabling the set of possible networks to be efficiently explored. As such, linear models with independent errors and conjugate priors are routinely used. However, the dynamics of molecular signalling are nonlinear, and relevant confounders are often unobserved; failure to account for these complexities will almost certainly lead to over-confident inferences in the standard Bayesian framework. To confront this reality, we develop a post-Bayesian approach to inference of molecular signalling networks, guided by the principle that uncertainty should not vanish when the statistical model is misspecified, even in the infinite-data limit. Technically, we extend the predictively-oriented (PrO) posterior of McLatchie et al. (2025) to the setting of latent variable models, empirically investigating the properties of PrO posteriors in the challenging network inference context.

stat.AP↗